In addition, serum levels of IL-6 and TNF-α are attenuated by treatment with RO-EO through regulation of the Janus kinase (JAK)/STAT/MAPK pathway in a DNCB-induced AD mouse model [84]. The gene discussed is TNF; the disease is Alzheimer disease.